标题
ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases
作者
关键词
-
出版物
HYPERTENSION
Volume 76, Issue 3, Pages 651-661
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2020-08-13
DOI
10.1161/hypertensionaha.120.15595
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2
- (2020) Renhong Yan et al. SCIENCE
- Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury
- (2020) Yingxia Liu et al. Science China-Life Sciences
- Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission
- (2020) Yuan Tian et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19
- (2020) Huilan Zhang et al. ANNALS OF INTERNAL MEDICINE
- Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
- (2020) Vanessa Monteil et al. CELL
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
- (2020) Shuai Xia et al. CELL RESEARCH
- β-Arrestin-Biased Angiotensin II Receptor Agonists for COVID-19
- (2020) Aashish Manglik et al. CIRCULATION
- Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19
- (2020) Peng Zhang et al. CIRCULATION RESEARCH
- Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System
- (2020) Mahmoud Gheblawi et al. CIRCULATION RESEARCH
- The pivotal link between ACE2 deficiency and SARS-CoV-2 infection
- (2020) Paolo Verdecchia et al. European Journal of Internal Medicine
- Angiotensin Converting Enzyme 2 and Angiotensin (1–7) axis in Pulmonary Arterial Hypertension
- (2020) Julio Sandoval et al. EUROPEAN RESPIRATORY JOURNAL
- Digestive system is a potential route of COVID-19: an analysis of single-cell coexpression pattern of key proteins in viral entry process
- (2020) Hao Zhang et al. GUT
- Altered Gut Microbiome Profile in Patients With Pulmonary Arterial Hypertension
- (2020) Seungbum Kim et al. HYPERTENSION
- Gut Pathology and Its Rescue by ACE2 (Angiotensin-Converting Enzyme 2) in Hypoxia-Induced Pulmonary Hypertension
- (2020) Ravindra K. Sharma et al. HYPERTENSION
- Prolonged viral shedding in feces of pediatric patients with coronavirus disease 2019
- (2020) Yu-Han Xing et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Structural basis of receptor recognition by SARS-CoV-2
- (2020) Jian Shang et al. NATURE
- Mechanisms by which angiotensin-receptor blockers increase ACE2 levels
- (2020) Carlos M. Ferrario et al. Nature Reviews Cardiology
- Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
- (2020) Xiuyuan Ou et al. Nature Communications
- Alterations of the Gut Microbiota in Patients With Coronavirus Disease 2019 or H1N1 Influenza
- (2020) Silan Gu et al. CLINICAL INFECTIOUS DISEASES
- Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review
- (2020) V. Montalvan et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Angiotensin‐converting enzyme inhibitors and angiotensin II receptor blockers are not associated with severe COVID‐19 infection in a multi‐site UK acute hospital trust
- (2020) Daniel M. Bean et al. EUROPEAN JOURNAL OF HEART FAILURE
- Expression of Human ACE2 in Lactobacillus and Beneficial Effects in Diabetic Retinopathy in Mice
- (2020) Amrisha Verma et al. Molecular Therapy-Methods & Clinical Development
- Microglial Cells Impact Gut Microbiota and Gut Pathology in Angiotensin II-Induced Hypertension
- (2019) Ravindra K Sharma et al. CIRCULATION RESEARCH
- Microbes, metabolites, and the gut–lung axis
- (2019) Anh Thu Dang et al. Mucosal Immunology
- Pulmonary artery denervation: a novel treatment modality for pulmonary hypertension
- (2019) Trixie Le et al. Journal of Thoracic Disease
- Bone Marrow-Derived Cells Restore Functional Integrity of the Gut Epithelial and Vascular Barriers in a Model of Diabetes and ACE2 Deficiency
- (2019) Yaqian Duan et al. CIRCULATION RESEARCH
- ACE2 exhibits protective effects against LPS-induced acute lung injury in mice by inhibiting the LPS-TLR4 pathway
- (2019) Rensong Ye et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- A potential therapeutic role for angiotensin-converting enzyme 2 in human pulmonary arterial hypertension
- (2018) Anna R. Hemnes et al. EUROPEAN RESPIRATORY JOURNAL
- Involvement of Neuroinflammation in the Pathogenesis of Monocrotaline-Induced Pulmonary HypertensionNovelty and Significance
- (2018) Ravindra K. Sharma et al. HYPERTENSION
- Involvement of Microglial Cells in Hypoxia-induced Pulmonary Hypertension
- (2018) Aline C. Oliveira et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- A metagenome-wide association study of gut microbiota in asthma in UK adults
- (2018) Qi Wang et al. BMC MICROBIOLOGY
- Roles of Angiotensin Peptides and Recombinant Human ACE2 in Heart Failure
- (2017) Ratnadeep Basu et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Ang-(1-7) is an endogenous β-arrestin-biased agonist of the AT1 receptor with protective action in cardiac hypertrophy
- (2017) Larissa B. Teixeira et al. Scientific Reports
- A Paradigm Shift Is Needed in the Field of Pulmonary Arterial Hypertension for Its Entrance Into the Precision Medicine Era
- (2016) Vikram Gurtu et al. CIRCULATION RESEARCH
- Increasing brain angiotensin converting enzyme 2 activity decreases anxiety-like behavior in male mice by activating central Mas receptors
- (2016) Lei Wang et al. NEUROPHARMACOLOGY
- Angiotensin-Converting Enzyme 2 Attenuates Bleomycin-Induced Lung Fibrosis in Mice
- (2015) Lifang Wang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Angiotensin-Converting Enzyme 2 Inhibits Apoptosis of Pulmonary Endothelial Cells During Acute Lung Injury Through Suppressing SMAD2 Phosphorylation
- (2015) Yong Ji et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- A novel ACE2 activator reduces monocrotaline-induced pulmonary hypertension by suppressing the JAK/STAT and TGF-β cascades with restored caveolin-1 expression
- (2014) Shiori Haga et al. EXPERIMENTAL LUNG RESEARCH
- Oral Delivery of Angiotensin-Converting Enzyme 2 and Angiotensin-(1-7) Bioencapsulated in Plant Cells Attenuates Pulmonary Hypertension
- (2014) Vinayak Shenoy et al. HYPERTENSION
- Downregulation of angiotensin-converting enzyme 2 by the neuraminidase protein of influenza A (H1N1) virus
- (2014) Xin Liu et al. VIRUS RESEARCH
- Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections
- (2014) Zhen Zou et al. Nature Communications
- Diminazene Attenuates Pulmonary Hypertension and Improves Angiogenic Progenitor Cell Functions in Experimental Models
- (2013) Vinayak Shenoy et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Minocycline: far beyond an antibiotic
- (2013) N Garrido-Mesa et al. BRITISH JOURNAL OF PHARMACOLOGY
- ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis
- (2013) AC Simões e Silva et al. BRITISH JOURNAL OF PHARMACOLOGY
- Diminazene aceturate improves autonomic modulation in pulmonary hypertension
- (2013) Katya Rigatto et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Diminazene Aceturate Enhances Angiotensin-Converting Enzyme 2 Activity and Attenuates Ischemia-Induced Cardiac Pathophysiology
- (2013) YanFei Qi et al. HYPERTENSION
- TMPRSS2 and ADAM17 Cleave ACE2 Differentially and Only Proteolysis by TMPRSS2 Augments Entry Driven by the Severe Acute Respiratory Syndrome Coronavirus Spike Protein
- (2013) A. Heurich et al. JOURNAL OF VIROLOGY
- ACE2 – From the renin–angiotensin system to gut microbiota and malnutrition
- (2013) Thomas Perlot et al. MICROBES AND INFECTION
- Upregulation of ACE2-ANG-(1–7)-Mas axis in jejunal enterocytes of type 1 diabetic rats: implications for glucose transport
- (2012) Tung Po Wong et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Intestinal peptidases form functional complexes with the neutral amino acid transporter B0AT1
- (2012) Stephen J. Fairweather et al. BIOCHEMICAL JOURNAL
- Loss of Angiotensin-Converting Enzyme-2 Exacerbates Diabetic Cardiovascular Complications and Leads to Systolic and Vascular Dysfunction
- (2012) Vaibhav B. Patel et al. CIRCULATION RESEARCH
- Interaction of diabetes and ACE2 in the pathogenesis of cardiovascular disease in experimental diabetes
- (2012) Chris Tikellis et al. CLINICAL SCIENCE
- Angiotensin converting enzyme 2 abrogates bleomycin-induced lung injury
- (2012) G. J. Rey-Parra et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation
- (2012) Tatsuo Hashimoto et al. NATURE
- Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist
- (2011) Roelie M Wösten-van Asperen et al. JOURNAL OF PATHOLOGY
- The Angiotensin-Converting Enzyme 2/Angiogenesis-(1–7)/Mas Axis Confers Cardiopulmonary Protection against Lung Fibrosis and Pulmonary Hypertension
- (2010) Vinayak Shenoy et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Angiotensin-Converting Enzyme 2 Suppresses Pathological Hypertrophy, Myocardial Fibrosis, and Cardiac Dysfunction
- (2010) JiuChang Zhong et al. CIRCULATION
- Recombinant angiotensin-converting enzyme 2 improves pulmonary blood flow and oxygenation in lipopolysaccharide-induced lung injury in piglets
- (2010) Benedikt Treml et al. CRITICAL CARE MEDICINE
- Brain Microglial Cytokines in Neurogenic Hypertension
- (2010) Peng Shi et al. HYPERTENSION
- Evidence for Angiotensin-converting Enzyme 2 as a Therapeutic Target for the Prevention of Pulmonary Hypertension
- (2009) Anderson J. Ferreira et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Mechanisms of hypoxic pulmonary vasoconstriction and their roles in pulmonary hypertension: new findings for an old problem
- (2009) Jeremy PT Ward et al. CURRENT OPINION IN PHARMACOLOGY
- Prevention of Pulmonary Hypertension by Angiotensin-Converting Enzyme 2 Gene Transfer
- (2009) Yoriko Yamazato et al. HYPERTENSION
- Targeting the Degradation of Angiotensin II With Recombinant Angiotensin-Converting Enzyme 2
- (2009) Jan Wysocki et al. HYPERTENSION
- Pulmonary fibrosis: pathogenesis, etiology and regulation
- (2009) M S Wilson et al. Mucosal Immunology
- Angiotensin converting enzyme-2 is protective but downregulated in human and experimental lung fibrosis
- (2008) Xiaopeng Li et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Structure and Mechanism of Metallocarboxypeptidases
- (2008) F. Gomis-Rüth CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More